Treating GvHD: current challenges and newly approved drugs

Graft versus host disease (GvHD) remains to be one of the leading causes of morbidity and mortality in patients who have undergone bone marrow transplant. Here, Katie Gatwood, PharmD, BCOP, of Vanderb... Author: VJHemOnc Added: 04/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts